Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
Health IT vendor IMS Health and biopharmaceutical research firm Quintiles Transnational Holdings have agreed to merge. Per the agreement, the companies will be combined in an all-stock merger of ...
IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results